Trials / Sponsors / Thomas Olencki
Thomas Olencki
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer Kidney Cancer | Phase 1 | 2008-02-01 |